Gordeev, Mikhail F

New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile. [electronic resource] - Journal of medicinal chemistry Jun 2014 - 4487-97 p. digital

Publication Type: Journal Article; Review

1520-4804

10.1021/jm401931e doi


Acetamides--adverse effects
Animals
Anti-Bacterial Agents--adverse effects
Bone Marrow Cells--cytology
Clinical Trials, Phase I as Topic
Drug Design
Drug Resistance, Bacterial
Gram-Positive Bacteria--drug effects
Gram-Positive Bacterial Infections--drug therapy
Humans
Linezolid
Monoamine Oxidase Inhibitors--chemistry
Oxazolidinones--adverse effects
Pyridones--adverse effects
Sepsis--drug therapy